Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas: Final results Meeting Abstract
| Authors: | Norden, A. D.; Schiff, D.; Ahluwalia, M. S.; Lesser, G. J.; Nayak, L.; Lee, E. Q.; Rinne, M. L.; Muzlkansky, A.; Dietrich, J.; Purow, B.; Smith, K. H.; Gaffey, S. C.; McCluskey, C. S.; Ligon, K. L.; Reardon, D. A.; Wen, P. Y. |
| Abstract Title: | Phase II trial of triple tyrosine kinase receptor inhibitor nintedanib in recurrent high-grade gliomas: Final results |
| Meeting Title: | 50th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 32 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2014 May 30-Jun 3 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2014-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358613202719 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2014.32.15_suppl.2053 |
| Notes: | Meeting Abstract: 2053 -- Source: Wos |
